Infection Testing
Epstein-Barr Virus Antibody to Viral Capsid Antigen VCA IgM Test
This test detects IgM antibodies to the Epstein-Barr Virus (EBV) viral capsid antigen, helping to identify a recent or acute EBV infection, often associated with infectious mononucleosis.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Serum (Blood sample)
- Results
- Confirm with the laboratory before booking.
- Preparation
- No special preparation is required. Confirm with the laboratory before booking.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the Epstein-Barr Virus Antibody to Viral Capsid Antigen VCA IgM Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Symptoms suggestive of infectious mononucleosis (e.g., fatigue, fever, sore throat, swollen lymph nodes)
- ✓Diagnosis of acute EBV infection
- ✓Differentiation from other illnesses with similar symptoms
- ✓Monitoring immune response in specific cases
In plain language
What this test helps you understand
This test specifically measures IgM antibodies, which are typically produced by the immune system early in an infection. The presence of VCA IgM antibodies suggests that an individual has recently been infected with EBV. This information is valuable for healthcare providers in diagnosing infectious mononucleosis and managing the patient's care.
Individuals experiencing symptoms consistent with infectious mononucleosis, such as significant fatigue, fever, sore throat, and swollen lymph nodes, may benefit from this test. It can help confirm a suspected diagnosis and differentiate it from other illnesses with similar symptoms.
Early detection of an acute EBV infection allows for appropriate medical guidance and management. While most EBV infections resolve on their own, understanding the stage of infection can be important, especially in individuals with weakened immune systems or those experiencing severe symptoms.
Results interpretation should always be done in consultation with a healthcare provider, who can consider the test results alongside your clinical presentation and medical history.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
1 3BetaDGlucan BDG Test
The 1 3BetaDGlucan BDG Test helps detect fungal infections by measuring beta-glucan levels in the blood. It is particularly useful for individuals with weakened immune systems or symptoms suggesting a fungal infection.
Learn more →Chlamydia IgG Antibody Panel Test
Detects past exposure to Chlamydia trachomatis and Chlamydophila pneumoniae infections by measuring IgG antibodies in the blood. Helps identify potential health risks.
Learn more →Dengue Fever IgG Antibody Test
The Dengue Fever IgG Antibody Test detects antibodies indicating a past dengue virus infection. It helps assess immunity and understand previous exposure.
Learn more →Chlamydophila Pneumoniae IgG Test
This test detects IgG antibodies to Chlamydophila pneumoniae, indicating a past infection with this bacterium, which can cause respiratory illnesses.
Learn more →